Showing results (141-150 of 197) with videos related to
Sort By:
Pageof 20
Cancer Research|November 5, 2014
Targeting of miR34a-NOTCH1 axis reduced breast cancer stemness and chemoresistanceEun Young Park, EunSun Chang, Eun Ji Lee, et al.Cell Reports. Medicine|November 7, 2024
Preclinical study and phase 2 trial of neoadjuvant pyrotinib combined with chemotherapy in luminal/HER2-low breast cancer: PILHLE-001 studyChang Gong, Yuan Xia, Yingying Zhu, et al.World Journal of Surgical Oncology|September 22, 2014
HER-2 positive breast cancer is associated with an increased risk of positive cavity margins after initial lumpectomyHaixia Jia, Weijuan Jia, Yaping Yang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2019
Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition TherapyYan Nie, Hongyan Huang, Mingyan Guo, et al.Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer|August 26, 2024
Chinese Society of Clinical Oncology (CSCO) Breast Cancer guidelines 2024Jianbin Li, Chunfang Hao, Kun Wang, et al.Cell Regeneration (London, England)|June 15, 2026
Standard: human breast cancer organoids derived from diverse clinical sample sourcesZhigang Chen, Ningning Xu, Ming Chen, et al.Nature Communications|August 23, 2019
Genotoxic stress-triggered β-catenin/JDP2/PRMT5 complex facilitates reestablishing glutathione homeostasisLixue Cao, Geyan Wu, Jinrong Zhu, et al.Cancer Cell|May 15, 2014
A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasisShicheng Su, Qiang Liu, Jingqi Chen, et al.Nature|December 13, 2023
Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptidesDi Huang, Xiaofeng Zhu, Shuying Ye, et al.Med (New York, N.Y.)|December 28, 2024
Targeting autophagy plus high-dose CDK4/6 inhibitors in advanced HR+HER2- breast cancer: A phase 1b/2 trialChang Gong, Qun Lin, Tao Qin, et al.Pageof 20